SS

Snehalata Satyaprakash Pandey

Active Director Director DIN 07801824
DIN 07801824 First appointment May 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since May 2017
Shareholding value •••• Premium profile

About Snehalata Satyaprakash Pandey

Data last updated:

Snehalata Satyaprakash Pandey is a Director at Zaria Pharmaceuticals Private Limited (since 2018), Director at Aidrich Management Consultancy Private Limited (since 2018) and Director at Nabhya Advertising And Marketing Services Privet Limited (since 2018), and holds 1 more current directorship. The companies operate in Pharma, Information Technology and Media and Publishing. The 3 current companies with reported revenue have a combined latest revenue of ₹2.92 Cr; the largest is Zaria Pharmaceuticals Private Limited at ₹2.69 Cr (FY 2025). Earlier, Snehalata Satyaprakash Pandey was a Designated Partner at Instaray Pharmaceuticals Llp (2017–2019).

DIN 07801824
Primary Designation Director
Industry Pharma
First Appointment 01 May 2017
Oldest Company Age 13 yrs
Largest company Zaria Pharmaceuticals Private Limited · ₹2.69 Cr (FY 2025)
Combined revenue ₹2.92 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Oct 20182018₹2.69 Cr (FY 2025)Active
Director31 Dec 20182012₹13.1 Lakh (FY 2025)Active
Director31 Dec 20182012₹10 Lakh (FY 2025)Active
Adeva Life Sciences Private Limited U24290MH2021PTC369220
Director09 Jul 20222021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner01 May 20172016Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Snehalata Satyaprakash Pandey

Directorship timeline

Open interactive timeline →
Zaria Pharmaceuticals Private Limited
Nabhya Advertising And Marketing Services Privet Limited
Aidrich Management Consultancy Private Limited
Adeva Life Sciences Private Limited
Premium access

Shareholding and investment profile for Snehalata Satyaprakash Pandey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Snehalata Satyaprakash Pandey

Snehalata Satyaprakash Pandey currently holds 4 directorships: Zaria Pharmaceuticals Private Limited (Director, since 17 Oct 2018, revenue ₹2.69 Cr (FY 2025)); Aidrich Management Consultancy Private Limited (Director, since 31 Dec 2018, revenue ₹13.1 Lakh (FY 2025)); Nabhya Advertising And Marketing Services Privet Limited (Director, since 31 Dec 2018, revenue ₹10 Lakh (FY 2025)); Adeva Life Sciences Private Limited (Director, since 09 Jul 2022).

Snehalata Satyaprakash Pandey was first appointed on 01 May 2017 as Designated Partner at Instaray Pharmaceuticals Llp. The most recent appointment on record is 09 Jul 2022 at Adeva Life Sciences Private Limited.

The 3 current companies of Snehalata Satyaprakash Pandey that report revenue have a combined latest revenue of ₹2.92 Cr: Zaria Pharmaceuticals Private Limited ₹2.69 Cr (FY 2025); Aidrich Management Consultancy Private Limited ₹13.1 Lakh (FY 2025); Nabhya Advertising And Marketing Services Privet Limited ₹10 Lakh (FY 2025).

Snehalata Satyaprakash Pandey held 1 earlier board appointment: Instaray Pharmaceuticals Llp (Designated Partner, 01 May 2017 to 18 Apr 2019).

The current boards of Snehalata Satyaprakash Pandey's companies include Satya Prakash Pandey (Zaria Pharmaceuticals Private Limited), Fabeeha Muqtada Khan (Adeva Life Sciences Private Limited), Zoya Aleem Siddiqui (Adeva Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available